Merck licenses Kenyan drug maker UCL to produce low-cost HIV prevention pill
Health and Wellness
Merck licenses Kenyan drug maker UCL to produce low-cost HIV prevention pill
The licensing agreement, announced by Merck on Friday, gives the Kiambu County-based company the right to manufacture or import the medicine and supply it to hospitals, pharmacies, government health programmes, non-governmental organisations and donor-funded initiatives in countries with high HIV burdens.
By David Abonyo